Aggregation promotes cell viability, proliferation, and differentiation in an in vitro model of injection cell therapy

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 10, 2012, Pages

  Bayoussef, Zahia ^a   Dixon, James E ^a   Stolnik, Snjezana ^a   Shakesheff, Kevin M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

C2C12 myoblasts; Cell delivery; Cell therapy; Differentiation; Engineered aggregation; Injection; Tissue engineering

Indexed keywords

AGGREGATES; CELL CULTURE; CELL ENGINEERING; TISSUE ENGINEERING;

C2C12 MYOBLASTS; CELL AGGREGATES; CELL DELIVERY; CELL THERAPY; DIFFERENTIATION; ENGINEERED AGGREGATION; IN-VITRO MODELS; INJECTION; SINGLE-CELL SUSPENSIONS; TISSUES ENGINEERINGS;

CELLS;

EID: 84866005080     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.482     Document Type: Article

References (54)

1. Agashi K, Chau DY et al. 2009; The effect of delivery via narrow-bore needles on mesenchymal cells. Regen Med 4: 49-64.
2. Assmus B, Schachinger V et al. 2003; Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): Migratory capacity of transplanted progenitor cells predicts functional improvement and infarct size reduction. Circulation 108: 311-311.
3. Baldwin SP, Krewson CE et al. 1996; PC12 cell aggregation and neurite growth in gels of collagen, laminin and fibronectin. Int J Dev Neurosci 14: 351-364.
4. Barbero A, Benelli R et al.. 2001; Growth factor supplemented Matrigel improves ectopic skeletal muscle formation - A cell therapy approach. J Cell Physiol 186: 183-192.
5. Bardouille C, Lehmann J et al. 2001; Growth and differentiation of permanent and secondary mouse myogenic cell lines on microcarriers. Appl Microbiol Biotechnol 55: 556-562.
6. Bazou D, Coakley WT et al. 2008; Long-term viability and proliferation of alginate-encapsulated 3-D HepG2 aggregates formed in an ultrasound trap. Toxicology in Vitro 22: 1321-1331.
7. Beauchamp JR, Morgan JE et al. 1999; Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. JBC 144: 1113-1121.
8. Bible E, Chau DYS et al. 2009; Attachment of stem cells to scaffold particles for intra-cerebral transplantation. Nat Protoc 4: 1440-1453.
9. Boland T, Mironov V et al. 2003; Cell and organ printing 2: Fusion of cell aggregates in three-dimensional gels. Anatomical Record Part a-Discoveries in Molecular Cellular and Evolutionary Biology 272A: 497-502.
10. Boontheekul T, Hill EE et al. 2007; Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng 13: 1431-1442.
11. Cheema U, Yang SY et al. 2003; 3-D in vitro model of early skeletal muscle development. Cell Motil Cytoskeleton 54: 226-236.
12. Chen CH, Chang Y et al. 2007; Construction and characterization of fragmented mesenchymal-stem-cell sheets for intramuscular injection. Biomaterials 28: 4643-4651.
13. Chen SL, Fang W et al. 2004; Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94: 92-95.
14. De Bank PA, Hou Q et al. 2007; Accelerated formation of multicellular 3-D structures by cell-to-cell cross-linking. Biotechnol Bioeng 97: 1617-1625.
15. De Bank PA, Kellam B et al. 2003; Surface engineering of living myoblasts via selective periodate oxidation. Biotechnol Bioeng 81: 800-808.
16. Dow J, Simkhovich BZ et al. 2005; Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy. Cardiovasc Res 67: 301-307.
17. Fox IJ, Chowdhury JR. 2004; Hepatocyte transplantation. Am. J. Transplant. 4: 7-13.
18. Frisch SM, Screaton RA. 2001; Anoikis mechanisms. Curr Opin Cell Biol 13: 555-562.
19. George-Weinstein M, Gerhart J et al. 1997; N-cadherin promotes the commitment and differentiation of skeletal muscle precursor cells. Dev Biol 185: 14-24.
20. Gussoni E, Pavlath GK et al. 1992; Normal Dystrophin Transcripts Detected in Duchenne Muscular-Dystrophy Patients after Myoblast Transplantation. Nature 356: 435-438.
21. Han Y, Liu XM et al. 2006; Cultivation of recombinant Chinese hamster ovary cells grown as suspended aggregates in stirred vessels. J Biosci Bioeng 102: 430-435.
22. Hegedus B, Marga F et al. 2006; The interplay of cell-cell and cell-matrix interactions in the invasive properties of brain tumors. Biophys J 91: 2708-2716.
23. Hudson W, Collins MC et al. 2007; Beating and arrested intramyocardial injections are associated with significant mechanical loss: Implications for cardiac cell transplantation. J Surg Res 142: 263-267.
24. Jakab K, Neagu A et al. 2004; Engineering biological structures of prescribed shape using self-assembling multicellular systems. PNAS 101: 2864-2869.
25. Karpati G, Ajdukovic D et al. 1993; Myoblast Transfer in Duchenne Muscular-Dystrophy. Ann Neurol 34: 8-17.
26. Kordower JH, Freeman TB et al. 1995; Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332: 1118-1124.
27. Li X, Lu S et al. 1999; Thyrotropin prevents apoptosis by promoting cell adhesion and cell cycle progression in FRTL-5 cells. Endocrinology 140: 5962-5970.
28. Lindvall O, Kokaia Z et al. 2004; Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 10(Suppl): S42-S50.
29. Livingston TL, Krewson CE et al. 1994; Cell-Migration and Aggregation in Protein Hydrogels. Abstr Pap Am Chem Soc 208: 164-POLY.
30. Mahoney MJ, Saltzman WM. 2001; Transplantation of brain cells assembled around a programmable synthetic microenvironment. Nat Biotechnol 19(10): 934-939.
31. Memon IA, Sawa Y et al. 2005; Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 130: 1333-1341.
32. Menasche P, Grp MMI et al. 2006. First randomized placebo-controlled Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial. Circulation 114: 2426-2426
33. Miljan EA, Sinden JD. 2009; Stem cell treatment of ischemic brain injury. Curr Opin Mol Ther 11: 394-403.
34. Mooney DJ, Vandenburgh H. 2008; Cell delivery mechanisms for tissue repair. Cell Stem Cell 2: 205-213.
35. Mooren F, Völker K. 2005; Molecular and cellular exercise physiology. Leeds, Human Kinetics: Champaign, Ill.
36. Nagy RD, Tsai BM et al. 2005; Stem cell transplantation as a therapeutic approach to organ failure. J Surg Res 129: 152-160.
37. Orive G, Hernandez RM et al. 2003; Survival of different cell lines in alginate-agarose microcapsules. Eur J Pharm Sci 18: 23-30.
38. Orive G, Ponce S et al. 2002; Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials 23: 3825-3831.
39. Petropoulos H, Skerjanc IS. 2002; beta-catenin is essential and sufficient for skeletal Myogenesis in P19 cells. J Biol Chem 277: 15393-15399.
40. Rhim C, Lowell DA et al. 2007; Morphology and ultrastructure of differentiating three-dimensional mammalian skeletal muscle in a collagen gel. Muscle Nerve 36: 71-80.
41. Rokstad AM, Donati I et al. 2006; Cell-compatible covalently reinforced beads obtained from a chemoenzymatically engineered alginate. Biomaterials 27: 4726-4737.
42. Ryu JH, Kim IK et al. 2005; Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26: 319-326.
43. Seghatoleslami MR, Myers L et al. 2000; Upregulation of myogenin by N-cadherin adhesion in three-dimensional cultures of skeletal myogenic BHK cells. J Cell Biochem 77: 252-264.
44. Siti-Ismail N, Bishop AE et al. 2008; The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29: 3946-3952.
45. Skerjanc IS, Slack RS et al. 1994; Cellular aggregation enhances MyoD-directed skeletal myogenesis in embryonal carcinoma cells. Mol Cell Biol 14: 8451-8459.
46. Skuk D, Paradis M et al. 2007; Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: Implications for cell-transplantation strategies. Transplantation 84: 1307-1315.
47. Veraitch FS, Scott R et al. 2008. The impact of manual processing on the expansion and directed differentiation of embryonic stem cells. Biotechnol Bioeng 99: 1216-1229.
48. Wakelam MJO. 1985; The Fusion of Myoblasts. Biochem J 228: 1-12.
49. Wang A, Adams G et al. 2009; Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J Biotech 144: 304-312.
50. Wang CC, Chen CH et al. 2008; Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res 77: 515-524.
51. Wollert KC, Meyer GP et al. 2004; Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148.
52. Wu TJ, Huang HH et al. 2007; A novel method of encapsulating and cultivating adherent mammalian cells within collagen microcarriers. Biotechnol Bioeng 98: 578-585.
53. Yaffe D, Saxel, O. 1977; Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
54. Yamada K, Kamihira M et al. 1999; Enhanced cell aggregation and liver functions using polymers modified with a cell-specific ligand in primary hepatocyte cultures. J Biosci Bioeng 88: 557-562.